Company
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
434 Legal Matters
67
367
0
OverviewLitigationPatentsTrademarksStatisticsNews

JANSSEN PHARMACEUTICALS (Johnson & Johnson) Company IP News and Updates

Knobbe Martens
•
Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar
Knobbe Martens
•
Dec 4, 2017
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s biosimilar,(1) ...
Read More
Showing 1-1 of 1 news found